Treatment, privacy concerns arise with availability of Alzheimer's test

11/15/2012 | New York Times (tiered subscription model), The

As more practices start to use imaging scans for diagnosing Alzheimer's disease, experts worry that the availability of the scans is getting ahead of availability of treatments for those who test positive. Treatment options are limited or not available for some forms of dementia. In one case, the family of an Arizona woman diagnosed with Alzheimer's through a scan refused to enroll her in an experimental study for fear of potential adverse side effects and instead turned to the Internet for treatments.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX